[1]
|
中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版) [J]. 实用肝脏病杂志, 2018, 21(2): 177-186.
|
[2]
|
孙长贵, 曾静, 孙婉璐, 等. 非酒精性脂肪性肝病患者估算的肾小球滤过率的变化及其影响因素分析[J]. 实用肝脏病杂志, 2017, 20(2): 165-170.
|
[3]
|
Wensveen, S.T., et al. (2016) Nonalcoholic Fatty Liver Disease—A Multisystem Disease? World Journal of Gastroenterology, 22, 9488-9505. https://doi.org/10.3748/wjg.v22.i43.9488
|
[4]
|
Eugene, H. and Yong-Ho, L. (2017) Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases. Diabetes & Metabolism Journal, 41, 430-437. https://doi.org/10.4093/dmj.2017.41.6.430
|
[5]
|
Zhang, J., Zhang, X., Zhao, Y., et al. (2018) Association between Urinary Alpha1-Microglobulin Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. Annals of Nutrition and Metabolism, 72, 30-36.
https://doi.org/10.1159/000484255
|
[6]
|
Targher, G. and Byrne, C.D. (2017) Non-Alcoholic Fatty Liver Disease: An Emerging Driving Force in Chronic Kidney Disease. Nature Reviews Nephrology, 13, 297-310. https://doi.org/10.1038/nrneph.2017.16
|
[7]
|
Dowman, J.K., Tomlinson, J.W. and Newsome, P.N. (2010) Pathogenesis of Non-Alcoholic Fatty Liver Disease. QJM, 103, 71-83. https://doi.org/10.1093/qjmed/hcp158
|
[8]
|
Tanaka, N., Kimura, T., Fujimori, N., et al. (2019) Current Status, Problems, and Perspectives of Non-Alcoholic Fatty Liver Disease Research. World Journal of Gastroenterology, 25, 163-177. https://doi.org/10.3748/wjg.v25.i2.163
|
[9]
|
Perry, R.J., Samuel, V.T., Petersen, K.F., et al. (2014) The Role of Hepatic Lipids in Hepatic Insulin Resistance and Type 2 Diabetes. Nature, 510, 84-91. https://doi.org/10.1038/nature13478
|
[10]
|
Dongiovanni, P., Meroni, M., Baselli, G.A., et al. (2017) Insulin Resistance Promotes Lysyl Oxidase like 2 Induction and Fibrosis Accumulation in Nonalcoholic Fatty Liver Disease. Clinical Science, 131, 1301-1315.
https://doi.org/10.1042/CS20170175
|
[11]
|
Spoto, B., Pisano, A. and Zoccali, C. (2016) Insulin Resistance in Chronic Kidney Disease: A Systematic Review. AJP Renal Physiology, 311, F1087-F1108. https://doi.org/10.1152/ajprenal.00340.2016
|
[12]
|
Hayashi, K., Kanda, T., Homma, K., et al. (2002) Altered Renal Microvascular Response in Zucker Obese Rats. Metabolism—Clinical & Experimental, 51, 1553-1561. https://doi.org/10.1053/meta.2002.36311
|
[13]
|
Irsik, D.L., Chen, J.K. and Brands, M.W. (2018) Chronic Renal Artery Insulin Infusion Increases Mean Arterial Pressure in Male Sprague Dawley Rats. American Journal of Physiology—Renal Physiology, 314, F81-F88.
https://doi.org/10.1152/ajprenal.00374.2017
|
[14]
|
Welsh, G.I., Hale, L.J., Eremina, V., et al. (2010) Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function. Cell Metabolism, 12, 329-340. https://doi.org/10.1016/j.cmet.2010.08.015
|
[15]
|
Lay, A.C., Hurcombe, J.A., Betin, V.M.S., et al. (2017) Prolonged Exposure of Mouse and Human Podocytes to Insulin Induces Insulin Resistance through Lysosomal and Proteasomal Degradation of the Insulin Receptor. Diabetologia, 60, 2299-2311. https://doi.org/10.1007/s00125-017-4394-0
|
[16]
|
Saleem, M.A. (2005) The Human Glomerular Podocyte Is a Novel Target for Insulin Action. Diabetes, 54, 3095-3102.
https://doi.org/10.2337/diabetes.54.11.3095
|
[17]
|
Marra, F. and Svegliati-Baroni, G. (2018) Lipotoxicity and the Gut-Liver Axis in NASH Pathogenesis. Journal of Hepatology, 68, 280-295. https://doi.org/10.1016/j.jhep.2017.11.014
|
[18]
|
Hebbard, L. and George, J. (2011) Animal Models of Nonalcoholic Fatty Liver Disease. Nature Reviews Gastroenterology & Hepatology, 8, 35-44. https://doi.org/10.1038/nrgastro.2010.191
|
[19]
|
Buzzetti, E., Pinzani, M. and Tsochatzis, E.A. (2016) The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Metabolism—Clinical & Experimental, 65, 1038-1048.
https://doi.org/10.1016/j.metabol.2015.12.012
|
[20]
|
Peter, M., Matthew, D., Suet-Wan, C., et al. (2015) Obesity-Related Chronic Kidney Disease—The Role of Lipid Metabolism. Metabolites, 5, 720-732. https://doi.org/10.3390/metabo5040720
|
[21]
|
Bowe, B., Xie, Y., Xian, H., et al. (2016) Low Levels of High-Density Lipoprotein Cholesterol Increase the Risk of Incident Kidney Disease and Its Progression. Kidney International, 89, 886-896.
https://doi.org/10.1016/j.kint.2015.12.034
|
[22]
|
Tao, J.L., Wen, Y.B., Shi, B.Y., et al. (2012) Endoplasmic Reticulum Stress Is Involved in Podocyte Apoptosis Induced by Saturated Fatty Acid Palmitate. Chinese Medical Journal, 125, 3137-3142.
|
[23]
|
Abrass, C.K. (2004) Cellular Lipid Metabolism and the Role of Lipids in Progressive Renal Disease. American Journal of Nephrology, 24, 46-53. https://doi.org/10.1159/000075925
|
[24]
|
Wahl, P., Ducasa, G.M. and Fornoni, A. (2016) Systemic and Renal Lipids in Kidney Disease Development and Progression. American Journal of Physiology Renal Physiology, 310, F433-F445.
https://doi.org/10.1152/ajprenal.00375.2015
|
[25]
|
Cao, Y., Hao, Y., Li, H., et al. (2014) Role of Endoplasmic Reticulum Stress in Apoptosis of Differentiated Mouse Podocytes Induced by High Glucose. International Journal of Molecular Medicine, 33, 809-816.
https://doi.org/10.3892/ijmm.2014.1642
|
[26]
|
Kaysen, G.A. (2009) New Insights into Lipid Metabolism in Chronic Kidney Disease: What Are the Practical Implications? Blood Purification, 27, 86-91. https://doi.org/10.1159/000167015
|
[27]
|
Stern, J.H., Rutkowski, J.M. and Scherer, P.E. (2016) Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. Cell Metabolism, 23, 770-784.
https://doi.org/10.1016/j.cmet.2016.04.011
|
[28]
|
Jung, U. and Choi, M.S. (2014) Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 15, 6184-6223. https://doi.org/10.3390/ijms15046184
|
[29]
|
Holland, W.L., Xia, J.Y., Johnson, J.A., et al. (2017) Inducible Overexpression of Adiponectin Receptors Highlight the Roles of Adiponectin-Induced Ceramidase Signaling in Lipid and Glucose Homeostasis. Molecular Metabolism, 6, 267-275. https://doi.org/10.1016/j.molmet.2017.01.002
|
[30]
|
Tsochatzis, E., Papatheodoridis, G.V. and Archimandritis, A.J. (2007) The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases. American Journal of Gastroenterology, 18, 2629-2640.
https://doi.org/10.1111/j.1572-0241.2006.00848.x
|
[31]
|
Zhao, S.G. (2018) Effect of Tonifying Kidney and Removing Phlegm on Adiponectin, Leptin, Interleukin-18 and Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver. Chinese Journal of Integrated Traditional & Western Medicine on Digestion, 26, 496-499.
|
[32]
|
Tardelli, M., Moreno-Viedma, V., Zeyda, M., et al. (2017) Adiponectin Regulates Aquaglyceroporin Expression in Hepatic Stellate Cells Altering Their Functional State. Journal of Gastroenterology & Hepatology, 32, 253-260.
https://doi.org/10.1111/jgh.13415
|
[33]
|
Guo, R., Nair, S., Zhang, Y., et al. (2017) Adiponectin Deficiency Rescues High-Fat Diet-Induced Hepatic Injury, Apoptosis and Autophagy Loss Despite Persistent Steatosis. International Journal of Obesity, 41, 1403-1412.
https://doi.org/10.1038/ijo.2017.128
|
[34]
|
Sharma, K. (2014) Obesity, Oxidative Stress, and Fibrosis in Chronic Kidney Disease. Kidney International Supplements, 4, 113-117. https://doi.org/10.1038/kisup.2014.21
|
[35]
|
Sharma, K., Ramacharaoandr, S., Qiu, G., et al. (2008) Adiponectin Regulates Albuminuria and Podocyte Function in Mice. Journal of Clinical Investigation, 118, 1645-1656. https://doi.org/10.1172/JCI32691
|
[36]
|
Knight, S.F. and Imig, J.D. (2007) Obesity, Insulin Resistance, and Renal Function. Microcirculation, 14, 349-362.
https://doi.org/10.1080/10739680701283018
|
[37]
|
Kou, H., Deng, J., Gao, D., et al. (2018) Relationship among Adiponectin, Insulin Resistance and Atherosclerosis in Non-Diabetic Hypertensive Patients and Healthy Adults. Clinical and Experimental Hypertension, 40, 1-8.
https://doi.org/10.1080/10641963.2018.1425414
|
[38]
|
Sasso, F.C., Pafundi, P.C., Marfella, R., et al. (2019) Adiponectin and Insulin Resistance Are Related to Restenosis and Overall New PCI in Subjects with Normal Glucose Tolerance: The Prospective AIRE Study. Cardiovascular Diabetology, 18, 24-37. https://doi.org/10.1186/s12933-019-0826-0
|
[39]
|
Peverill, W., Powell, L. and Skoien, R. (2014) Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation. International Journal of Molecular Sciences, 15, 8591-8638. https://doi.org/10.3390/ijms15058591
|
[40]
|
Sumida, Y., Niki, E., Naito, Y., et al. (2013) Involvement of Free Radicals and Oxidative Stress in NAFLD/NASH. Free Radical Research, 47, 869-880. https://doi.org/10.3109/10715762.2013.837577
|
[41]
|
Mann, J.P., Raponi, M. and Nobili, V. (2017) Clinical Implications of Understanding the Association between Oxidative Stress and Pediatric NAFLD. Expert Review of Gastroenterology & Hepatology, 11, 371-382.
https://doi.org/10.1080/17474124.2017.1291340
|
[42]
|
Spahis, S., Delvin, E., Borys, J.M., et al. (2016) Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis. Antioxidants & Redox Signaling, 26, 519-541. https://doi.org/10.1089/ars.2016.6776
|
[43]
|
Liberal, R., Grant, C.R., Mieli-Vergani, G., et al. (2013) Autoimmune Hepatitis: A Comprehensive Review. Journal of Autoimmunity, 41, 126-139. https://doi.org/10.1016/j.jaut.2012.11.002
|
[44]
|
Hotamisligil, G.S. (2006) Inflammation and Metabolic Disorders. Current Opinion in Clinical Nutrition & Metabolic Care, 11, 459-464.
|
[45]
|
Takaki, A., Kawai, D. and Yamamoto, K. (2013) Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH). International Journal of Molecular Sciences, 14, 20704-20728. https://doi.org/10.3390/ijms141020704
|
[46]
|
Fujita, N., Miyachi, H., Tanaka, H., et al. (2009) Iron Overload Is Associated with Hepatic Oxidative Damage to DNA in Nonalcoholic Steatohepatitis. Cancer Epidemiology Biomarkers & Prevention, 50, S372-S373.
https://doi.org/10.1158/1055-9965.EPI-08-0725
|
[47]
|
Katsoulieris, E., Mabley, J.G., Samai, M., et al. (2010) Lipotoxicity in Renal Proximal Tubular Cells: Relationship between Endoplasmic Reticulum Stress and Oxidative Stress Pathways. Free Radical Biology and Medicine, 48, 1654-1662. https://doi.org/10.1016/j.freeradbiomed.2010.03.021
|
[48]
|
Rong, G., Tang, X., Guo, T., et al. (2015) Advanced Oxidation Protein Products Induce Apoptosis in Podocytes through Induction of Endoplasmic Reticulum Stress. Journal of Physiology & Biochemistry, 71, 455-470.
https://doi.org/10.1007/s13105-015-0424-x
|
[49]
|
Boini, K.M., Xia, M., Abais, J.M., et al. (2014) Activation of Inflammasomes in Podocyte Injury of Mice on the High Fat Diet: Effects of ASC Gene Deletion and Silencing. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1843, 836-845. https://doi.org/10.1016/j.bbamcr.2014.01.033
|
[50]
|
Masarone, M. (2014) Non Alcoholic Fatty Liver: Epidemiology and Natural History. Reviews on Recent Clinical Trials, 9, 126-133. https://doi.org/10.2174/1574887109666141216111143
|
[51]
|
Zhang, Q., Li, Y., Liang, T., et al. (2015) ER Stress and Autophagy Dysfunction Contribute to Fatty Liver in Diabetic Mice. International Journal of Biological Sciences, 11, 559-568. https://doi.org/10.7150/ijbs.10690
|
[52]
|
Fujii, J., Homma, T., Kobayashi, S., et al. (2018) Mutual Interaction between Oxidative Stress and Endoplasmic Reticulum Stress in the Pathogenesis of Diseases Specifically Focusing on Non-Alcoholic Fatty Liver Disease. World Journal of Biological Chemistry, 9, 4-18. https://doi.org/10.4331/wjbc.v9.i1.1
|
[53]
|
Cunard, R. and Sharma, K. (2011) The Endoplasmic Reticulum Stress Response and Diabetic Kidney Disease. AJP: Renal Physiology, 300, F1054-F1061. https://doi.org/10.1152/ajprenal.00021.2011
|
[54]
|
Duan, H.J. (2014) Role of Endoplasmic Reticulum Stress in Apoptosis of Differentiated Mouse Podocytes Induced by High Glucose. International Journal of Molecular Medicine, 33, 809-816. https://doi.org/10.3892/ijmm.2014.1642
|
[55]
|
Kampe, K., Sieber, J., Orellana, J.M., et al. (2014) Susceptibility of Podocytes to Palmitic Acid Is Regulated by Fatty Acid Oxidation and Inversely Depends on Acetyl-CoA Carboxylases 1 and 2. AJP: Renal Physiology, 306, F401-F409.
https://doi.org/10.1152/ajprenal.00454.2013
|
[56]
|
Sieber, J., Lindenmeyer, M.T., Kampe, K., et al. (2010) Regulation of Podocyte Survival and Endoplasmic Reticulum Stress by Fatty Acids. American Journal of Physiology Renal Physiology, 299, F821-F829.
https://doi.org/10.1152/ajprenal.00196.2010
|
[57]
|
Garner, K.L., Betin, V.M.S., Pinto, V., et al. (2018) Enhanced Insulin Receptor, But Not PI3K, Signalling Protects Podocytes from ER Stress. Scientific Reports, 8, 3902-3915. https://doi.org/10.1038/s41598-018-22233-9
|
[58]
|
Qiu, M., Li, S., Jin, L., et al. (2018) Combination of Chymostatin and Aliskiren Attenuates ER Stress Induced by Lipid Overload in Kidney Tubular Cells. Lipids in Health and Disease, 17, 183-194.
https://doi.org/10.1186/s12944-018-0818-1
|
[59]
|
Parambir, S., Dulai, S.D., Janki, P., et al. (2017) Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Hepatology, 65, 1557-1565. https://doi.org/10.1002/hep.29085
|
[60]
|
Adams, L.A., Anstee, et al. (2017) Non-Alcoholic Fatty Liver Disease and Its Relationship with Cardiovascular Disease and Other Extrahepatic Diseases. Gut: Journal of the British Society of Gastroenterology, 66, 1138-1153.
https://doi.org/10.1136/gutjnl-2017-313884
|